Literature DB >> 3729400

Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.

L W Robertson, A Chandrasekaran, R H Reuning, J Hui, B D Rawal.   

Abstract

The anaerobic bacterium Eubacterium lentum, a common constituent of the intestinal microflora, inactivates digoxin by reducing the unsaturated lactone ring. Reduction of the cardiac glycoside by growing cultures of E. lentum ATCC 25559 proceeded in a stereospecific manner, with the 20R-dihydrodigoxin constituting more than 99% of the product formed. This is in contrast to the 3:1 ratio of 20R and 20S epimers formed in the chemical catalytic hydrogenation. Formation of the reduced glycosides proceeded quantitatively when an overall concentration of 10 micrograms/ml was added to the cultures. E. lentum did not hydrolyze the digitoxose sugars from C-3 of the parent glycoside. However, the synthetically prepared sugar-hydrolyzed metabolites (digoxigenin, digoxigenin monodigitoxoside, and digoxigenin bisdigitoxoside) were reduced to the corresponding dihydro metabolites. Repetition of the experiments with a feces sample from a volunteer who was known to be a converter of digoxin to dihydrodigoxin gave results identical to those obtained with pure E. lentum cultures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729400      PMCID: PMC239061          DOI: 10.1128/aem.51.6.1300-1303.1986

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  Identification by gas chromatography-mass spectroscopy of dihydrodigoxin--a metabolite of digoxin in man.

Authors:  E Watson; D R Clark; S M Kalman
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

2.  Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.

Authors:  D G Rund; J Lindenbaum; J F Dobkin; V P Butler; J R Saha
Journal:  Clin Pharmacol Ther       Date:  1983-12       Impact factor: 6.875

3.  Dihydrodigoxin: a common metabolite of digoxin in man.

Authors:  D R Clark; S M Kalman
Journal:  Drug Metab Dispos       Date:  1974 Mar-Apr       Impact factor: 3.922

4.  Isolation and characterization of fecal bacteria capable of 16 alpha-dehydroxylating corticoids.

Authors:  V D Bokkenheuser; J Winter; S O'Rourke; A E Ritchie
Journal:  Appl Environ Microbiol       Date:  1980-10       Impact factor: 4.792

5.  Digoxigenin biotransformation.

Authors:  H Gault; J Kalra; L Longerich; M Dawe
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

6.  Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.

Authors:  J Lindenbaum; D G Rund; V P Butler; D Tse-Eng; J R Saha
Journal:  N Engl J Med       Date:  1981-10-01       Impact factor: 91.245

7.  Biotransformation of linoleic acid and bile acids by Eubacterium lentum.

Authors:  H Eyssen; A Verhulst
Journal:  Appl Environ Microbiol       Date:  1984-01       Impact factor: 4.792

8.  Digoxin-inactivating bacteria: identification in human gut flora.

Authors:  J R Saha; V P Butler; H C Neu; J Lindenbaum
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

9.  Transformation of bile acids by Eubacterium lentum.

Authors:  S Hirano; N Masuda
Journal:  Appl Environ Microbiol       Date:  1981-11       Impact factor: 4.792

10.  Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora.

Authors:  J F Dobkin; J R Saha; V P Butler; H C Neu; J Lindenbaum
Journal:  Trans Assoc Am Physicians       Date:  1982
View more
  10 in total

Review 1.  Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?

Authors:  Lingeng Lu; Yixing Wu; Lingjun Zuo; Xingguang Luo; Peter J Large
Journal:  World J Microbiol Biotechnol       Date:  2013-10-09       Impact factor: 3.312

2.  Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora.

Authors:  V I Mathan; J Wiederman; J F Dobkin; J Lindenbaum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

Review 3.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

4.  Reductive inactivation of digitoxin by Eubacterium lentum cultures.

Authors:  A Chandrasekaran; L W Robertson; R H Reuning
Journal:  Appl Environ Microbiol       Date:  1987-04       Impact factor: 4.792

5.  Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.

Authors:  Jun R Huh; Monica W L Leung; Pengxiang Huang; Daniel A Ryan; Michael R Krout; Raghu R V Malapaka; Jonathan Chow; Nicolas Manel; Maria Ciofani; Sangwon V Kim; Adolfo Cuesta; Fabio R Santori; Juan J Lafaille; H Eric Xu; David Y Gin; Fraydoon Rastinejad; Dan R Littman
Journal:  Nature       Date:  2011-03-27       Impact factor: 49.962

Review 6.  The Historical Development of Cultivation Techniques for Methanogens and Other Strict Anaerobes and Their Application in Modern Microbiology.

Authors:  Nikola Hanišáková; Monika Vítězová; Simon K-M R Rittmann
Journal:  Microorganisms       Date:  2022-02-10

Review 7.  Interplays between drugs and the gut microbiome.

Authors:  Yating Wan; Tao Zuo
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-04-08

Review 8.  Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.

Authors:  Jun R Huh; Dan R Littman
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

Review 9.  Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.

Authors:  Gabriel Tao; Junqing Huang; Bhagavatula Moorthy; Cathryn Wang; Ming Hu; Song Gao; Romi Ghose
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-09-02       Impact factor: 4.481

Review 10.  Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice.

Authors:  Chaonan Sun; Ling Chen; Zhu Shen
Journal:  Saudi Pharm J       Date:  2019-10-24       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.